Helping cancer patients quit smoking with a smartphone app
Quit2Heal: Rigorous Randomized Trial of a Smartphone Application to Help Cancer Patients Stop Smoking
['FUNDING_R01'] · FRED HUTCHINSON CANCER CENTER · NIH-10843262
This study is testing a smartphone app that helps cancer patients quit smoking, making it easier and more affordable for those who still smoke after their diagnosis to get support and improve their health.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | FRED HUTCHINSON CANCER CENTER (nih funded) |
| Locations | 1 site (SEATTLE, UNITED STATES) |
| Trial ID | NIH-10843262 on ClinicalTrials.gov |
What this research studies
This research investigates the effectiveness of a smartphone application designed to assist cancer patients in quitting smoking. It aims to provide a low-cost and accessible intervention for those who continue to smoke after their cancer diagnosis, which is known to worsen clinical outcomes. The study will explore how well the app works, why it may be effective, and which patients are most likely to benefit from using it. By utilizing technology, the research seeks to overcome barriers to accessing traditional smoking cessation programs.
Who could benefit from this research
Good fit: Ideal candidates for this research are cancer patients who currently smoke and are seeking help to quit.
Not a fit: Patients who do not smoke or have already successfully quit smoking may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve smoking cessation rates among cancer patients, leading to better health outcomes and reduced mortality.
How similar studies have performed: While the use of smartphone apps for smoking cessation is a growing field, this specific approach targeting cancer patients is relatively novel and has not been extensively tested.
Where this research is happening
SEATTLE, UNITED STATES
- FRED HUTCHINSON CANCER CENTER — SEATTLE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: BRICKER, JONATHAN B — FRED HUTCHINSON CANCER CENTER
- Study coordinator: BRICKER, JONATHAN B
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Cancers, neoplasm/cancer